568
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Development of a physiologically based pharmacokinetic model of diisononyl phthalate (DiNP) in pregnant rat and human

, , , , , & show all

References

  • Abduljalil, K., P. Furness, T. N. Johnson, A. Rostami-Hodjegan, and H. Soltani. 2012. Physiological, anatomical and metabolic changes with gestational age during normal pregnancy: Creating a database and analysing trends for parameters required in physiologically based pharmacokinetic modelling. Clin Pharmacokinet 51:365–96.
  • Anderson, W. A., L. Castle, S. Hird, J. Jeffery, and M. J. Scotter. 2011. A twenty-volunteer study using deuterium labelling to determine the kinetics and fractional excretion of primary and secondary urinary metabolites of di-2-ethylhexylphthalate and di-iso-nonylphthalate. Food Chem. Toxicol. 49:2022–29.
  • Boekelheide, K., E. Kleymenova, K. Liu, C. Swanson, and K. W. Gaido. 2009. Dose-dependent effects on cell proliferation, seminiferous tubules, and male germ cells in the fetal rat testis following exposure to di(n-butyl) phthalate. Microsc. Res. Tech. 72:629–38.
  • Bois, F. 2009. GNU MCSim: Bayesian statistical inference for SBML-coded systems biology models. Bioinformatics 25:1453–54.
  • Borch, J., O. Ladefoged, U. Hass, and A. M. Vinggaard. 2004. Steroidogenesis in fetal male rats is reduced by DEHP and DiNP, but endocrine effects of DEHP are not modulated by DEHA in fetal, prepubertal and adult male rats. Reprod. Toxicol. 18:53–61.
  • Brown, R. P., M. D. Delp, S. L. Lindstedt, L. R. Rhomberg, and R. P. Beliles. 1997. Physiological parameter values for physiologically based pharmacokinetic models. Toxicol. Ind. Health 13:407–84.
  • Buelke-Sam, J., C. J. Nelson, R. A. Byrd, and J. F. Holson. 1982. Blood flow during pregnancy in the rat: I. Flow patterns to maternal organs. Teratology 26:269–77.
  • Campbell, J. L., Jr, M. Yoon, P. L. Ward, H. Fromme, W. Kessler, M. B. Phillips, W. A. Anderson, H. J. Clewell 3rd, and M. P. Longnecker. 2018. Excretion of di-2-ethylhexyl phthalate (DEHP) metabolites in urine is related to body mass index because of higher energy intake in the overweight and obese. Environ. Int. 113:91–99.
  • Chemical Book. 2019. Monoisononyl Phthalate. Accessed August 20. https://www.chemicalbook.com/ProductList_en.aspx?kwd=MONOisononYL%20PHTHALATE
  • Chemspider. 2019a. Diisononylphthalate, Chemical ID: 513622. Accessed August 20. http://www.chemspider.com/Chemical-Structure.513622.html?rid=091c002b-14a6-44ab-a0ba-c2891b152bee
  • Chemspider. 2019b. Monoisononyl Phthalate, Chemical ID: 99110. Accessed August 2. http://www.chemspider.com/Chemical-Structure.99110.html
  • Chung, B. Y., S. M. Choi, T. H. Roh, D. S. Lim, M. Y. Ahn, Y. J. Kim, H. S. Kim, and B. M. Lee. 2019. Risk assessment of phthalates in pharmaceuticals. J. Toxicol. Environ. Health Part A 82:351–60.
  • Clewell, R. A., A. Thomas, G. Willson, D. M. Creasy, and M. E. Andersen. 2013b. A dose response study to assess effects after dietary administration of diisononyl phthalate (DiNP) in gestation and lactation on male rat sexual development. Reprod. Toxicol. 35:70–80.
  • Clewell, R. A., E. A. Merrill, K. O. Yu, D. A. Mahle, T. R. Sterner, D. R. Mattie, P. J. Robinson, J. W. Fisher, and J. M. Gearhart. 2003. Predicting fetal perchlorate dose and inhibition of iodide kinetics during gestation: A physiologically-based pharmacokinetic analysis of perchlorate and iodide kinetics in the rat. Toxicol. Sci. 73:235–55.
  • Clewell, R. A., J. J. Kremer, C. C. Williams, J. J. Campbell, M. A. Sochaski, M. E. Andersen, S. J. Borghoff. 2009. Kinetics of selected di-n-butyl phthalate metabolites and fetal testosterone following repeated and single administration in pregnant rats. Toxicol. Appl. Pharmacol. 255:80–90.
  • Clewell, R. A., J. J. Kremer, C. C. Williams, J. L. Campbell Jr, M. E. Andersen, and S. J. Borghoff. 2008. Tissue exposures to free and glucuronidated monobutylyphthalate in the pregnant and fetal rat following exposure to di-n-butylphthalate: Evaluation with a PBPK model. Toxicol. Sci. 103:241–59.
  • Clewell, R. A., M. Sochaski, K. Edwards, D. M. Creasy, G. Willson, and M. E. Andersen. 2013a. Disposition of diisononyl phthalate and its effects on sexual development of the male fetus following repeated dosing in pregnant rats. Reprod. Toxicol. 35:56–69.
  • Dorman, D. C., W. Chiu, B. F. Hales, R. Hauser, K. J. Johnson, E. Mantus, S. Martel, K. A. Robinson, A. A. Rooney, R. Rudel, et al. 2018. Systematic reviews and meta-analyses of human and animal evidence of prenatal diethylhexyl phthalate exposure and changes in male anogenital distance. J. Toxicol. Environ. Health B 21:207–26.
  • ECHA. (2013). Evaluation of new scientific evidence concerning DiNP and DIDP In relation to entry 52 of Annex XVII to REACH Regulation (EC) No 1907/2006, Final review report. Accessed August 5, 2019. https://echa.europa.eu/documents/10162/31b4067e-de40-4044-93e8-9c9ff1960715
  • Gaido, K. W., J. B. Hensley, D. Liu, D. G. Wallace, S. Borghoff, K. J. Johnson, S. J. Hall, K. Boekelheide. 2007. Fetal mouse phthalate exposure shows that gonocyte multinucleation is not associated with decreased testicular testosterone. Toxicol. Sci. 97:491–503.
  • Gaohua, L., K. Abduljalil, M. Jamei, T. N. Johnson, and A. Rostami-Hodjegan. 2012. A pregnancy physiologically based pharmacokinetic (p-PBPK) model for disposition of drugs metabolized by CYP1A2, CYP2D6 and CYP3A4. Br. J. Clin. Pharmacol. 74:873–85.
  • Gentry, P. R., H. J. Clewell 3rd, R. Clewell, J. Campbell, C. Van Landingham, and A. M. Shipp. 2011. Challenges in the application of quantitative approaches in risk assessment: A case study with di-(2-ethylhexyl) phthalate. Crit. Rev. Toxicol. 41 (Suppl 2):1–72.
  • Han, S. W., H. Lee, S. Y. Han, D. S. Lim, K. K. Jung, S. J. Kwack, K. B. Kim, and B. M. Lee. 2009. An exposure assessment of di-(2-ethylhexyl) phthalate (DEHP) and di-n-butyl phthalate (DBP) in human semen. J. Toxicol. Environ. Health Part A 72:1463–69.
  • Hannas, B. R., C. S. Lambright, J. Furr, K. L. Howdeshell, V. S. Wilson, and L. E. Gray Jr. 2011. Dose–response assessment of fetal testosterone production and gene expression levels in rat testes following in utero exposure to diethylhexyl phthalate, diisobutyl phthalate, diisoheptyl phthalate and diisononyl phthalate. Toxicol. Sci. 123:206–16.
  • Hanwell, A., and J. L. Linzell. 1973. The time course of cardiovascular changes in the rat. J. Physiol. (Lond.) 233:99–109.
  • Hou, M. L., L. W. Chang, C. J. Chiang, Y. H. Tsuang, C. H. Lin, and T. H. Tsai. 2013. Pharmacokinetics of di-isononyl phthalate in freely moving rats by UPLC-MS/MS. Int. J. Pharm. 25:36–43.
  • ICRP. 2002. Basic anatomical and physiological data for use in radiological protection reference values. ICRP Publication 89. Ann. ICRP 32 (3-4).
  • Kessler, W., W. Numtip, W. Völkel, E. Seckin, G. A. Csanády, C. Pütz, D. Klein, H. Fromme, and J. G. Filser. 2012. Kinetics of di(2-ethylhexyl) phthalate (DEHP) and mono(2-ethylhexyl) phthalate in blood and of DEHP metabolites in urine of male volunteers after single ingestion of ring-deuterated DEHP. Toxicol. Appl. Pharmacol. 264:284–91.
  • Knight, C. H., and M. Peaker. 1982. Mammary cell proliferation in mice during pregnancy and lactation in relation to milk yield. Quart.J. Exp. Physiol. 67:165–77.
  • Koch, H. M., A. Haller, T. Weiss, H.-U. Käfferlein, J. Stork, and T. Brüning. 2012. Phthalate exposure during cold plastisol application—a human biomonitoring study. Toxicol. Lett. 213:100–06.
  • Koch, H. M., and J. Angerer. 2007. Di-iso-nonylphthalate (DiNP) metabolites in human urine after a single oral dose of deuterium-labelled DiNP. Int. J. Hyg. Environ. Health 210:9–19.
  • Koch, H. M., M. Lorber, K. L. Christensen, C. Pälmke, S. Koslitz, and T. Brüning. 2013. Identifying sources of phthalate exposure with human biomonitoring: Results of a 48 h fasting study with urine collection and personal activity patterns. Int. J. Hyg. Environ. Health 216:672–81.
  • Kransler, K. M., A. N. Bachman, and R. H. McKee. 2012. A comprehensive review of intake estimates of di-isononyl phthalate (DiNP) based on indirect exposure models and urinary biomonitoring data. Regul. Toxicol. Pharmacol. 62:248–56.
  • LaBorde, J. B., D. K. Hansen, J. F. Young, D. M. Sheehan, and R. R. Holson. 1992. Prenatal dexamethasone exposure in rats: Effects of dose, age at exposure, and drug-induced hypophagia on malformations and fetal organ weights. Fundam. Appl. Toxicol. 19:545–54.
  • Lehmann, K. P., S. Phillips, M. Sar, P. M. Foster, and K. W. Gaido. 2004. Dose-dependent alterations in gene expression and testosterone synthesis in the fetal testes of male rats exposed to di(n-butyl) phthalate. Toxicol. Sci. 81:60–68.
  • Lucier, G. W., B. R. Sonawane, O. S. McDaniel, and G. E. Hook. 1975. Postnatal stimulation of hepatic microsomal enzymes following administration of TCDD to pregnant rats. Chem. Biol. Interact. 11:15–26.
  • Lucier, G. W., and O. S. McDaniel. 1977. Steroid and non-steroid UDP glucuronyltransferase: Glucuronidation of synthetic estrogens as steroids. J. Steroid Biochem. 8:867–72.
  • Moreau, M., J. Leonard, K. A. Phillips, J. Campbell, S. N. Pendse, C. Nicolas, M. Phillips, M. Yoon, Y. M. Tan, S. Smith, et al. 2017. Using exposure prediction tools to link exposure and dosimetry for risk-based decisions: A case study with phthalates. Chemosphere 184:1194–201.
  • Mylchreest, E., D. G. Wallace, R. C. Cattley, and P. M. Foster. 2000. Dose-dependent alterations in androgen-regulated male reproductive development in rats exposed to di(n-butyl) phthalate during late gestation. Toxicol. Sci. 55:143–51.
  • Mylchreest, E., M. Sar, D. G. Wallace, and P. M. Foster. 2002. Fetal testosterone insufficiency and abnormal proliferation of Leydig cells and gonocytes in rats exposed to di(n-butyl) phthalate. Repro. Toxicol. 16:19–28.
  • Mylchreest, E., M. Sar, R. C. Cattley, and P. M. D. Foster. 1999. Disruption of androgen-regulated male reproductive development by di(n-butyl) phthalate during late gestation in rats is different from flutamide. Toxicol. Appl. Pharmacol. 156:81–95.
  • Mylchreest, E., R. C. Cattley, and P. M. D. Foster. 1998. Male reproductive tract malformations in rats following gestational and lactational exposure to di(n-butyl) phthalate: An antiandrogenic mechanism? Toxicol. Sci. 43:47–60.
  • Naessany, S., and R. Picon. 1982. Onset of a feedback inhibition by testosterone in male rat fetuses. Biol. Neonate. 41:234–39.
  • Naismith, D. J., D. P. Richardson, and A. E. Pritchard. 1982. The utilization of protein and energy during lactation in the rat, with particular regard to the use of fat accumulated during pregnancy. Br. J. Nutr. 48:433–41.
  • NICNAS. (2012). Priority existing chemical assessment report No.35: Diisononyl phthalate, ISBN 978-0-9807221-8-5. accessed August 5, 2019. https://www.nicnas.gov.au/__data/assets/word_doc/0008/34838/PEC35-DiNP.docx
  • O’Flaherty, E. J., W. Scott, C. Schreiner, and R. P. Beliles. 1992. A physiologically based kinetic model of rat and mouse gestation: Disposition of a weak acid. Toxicol. Appl. Pharmacol. 112:245–56.
  • Park, H. W., and T. H. Shepard. 1994. Volume and glucose concentration of rat amniotic fluid: Effects on embryo nutrition and axis rotation. Teratology 49:465–69.
  • Parks, L. G., J. S. Ostby, C. R. Lambright, B. D. Abbott, G. R. Klinefelter, N. J. Barlow, and L. E. Gray Jr. 2000. The plasticizer diethylhexyl phthalate induces malformations by decreasing fetal testosterone synthesis during sexual differentiation in the male rat. Toxicol. Sci. 58:339–49.
  • Ruark, C. D., E. Hack, P. J. Robinson, D. Mahle, and J. Gearhart. 2014. Predicting passive and active tissue: Plasmapartition coefficients: Interindividual and interspecies variability. J. Pharmaceut. Sci. 103:2189–98.
  • Saillenfait, A. M., J. P. Sabaté, A. Robert, B. Cossec, A. C. Roudot, F. Denis, and M. Burgart. 2013. Adverse effects of diisooctyl phthalate on the male rat reproductive development following prenatal exposure. Reprod. Toxicol. 42:192–202.
  • Saillenfait, A. M., J. P. Sabaté, and F. Gallissot. 2006. Developmental toxic effects of diisobutyl phthalate, the methyl-branched analogue of di-n-butyl phthalate, administered by gavage to rats. Toxicol. Lett. 165:39–46.
  • Schütze, A., R. Otter, H. Modick, A. Langsch, T. Brüning, and H. M. Koch. 2017. Additional oxidized and alkyl chain breakdown metabolites of the plasticizer DINCH in urine after oral dosage to human volunteers. Arch. Toxicol. 91:179–88.
  • Soetaert, K., T. Petzoldt, and R. Setzer. 2010a. Solving differential equations in R: Package deSolve. J. Stat. Softw. 33 (9):1–25. http://www.jstatsoft.org/v33/i09.
  • Soetaert, K., T. Petzoldt, and R. W. Setzer. 2010b. deSolve: General solvers for initial value problems of ordinary differential equations (ODE), partial differential equations (PDE), differential algebraic equations (DAE) and delay differential equations (DDE). R package version 1.8.
  • Thompson, R. C., and O. L. Hollis. 1958. Irradiation of the gastrointestinal tract of the rat by ingested ruthenium-96. Am. J. Physiol. 194:308–12.
  • USCPSC. 2014. Chronic hazard advisory panel on phthalates and phthalate alternatives. Accessed August 5, 2019. https://www.cpsc.gov/s3fs-public/ToxicityReviewOfDiNP.pdf
  • Wishart, G. J. 1978. Functional heterogeneity of UDP-glucuronosyltransferase as indicated by its differential development and inducibility by glucocorticoids. Demonstration of two groups within the enzyme’s activity towards twelve substrates. Biochem. J. 174:485–89.
  • Wykoff, M. H. 1971. Weight changes of the developing rat conceptus. Am. J. Vet. Res. 32:1633–35.
  • Ypma, J., S. G. Johnson, H. W. Borchers, D. Eddelbuettel, B. Ripley, K. Hornik, J. Chiquet, and A. Adler, 2020. Nloptr: R Interface to NLopt. Accessed January 10, 2020. https://cran.r-project.org/web/packages/nloptr/index.html

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.